Showing results (411-420 of 3,013) with videos related to

Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|July 7, 2021
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes MellitusYochai Birnbaum, Huan Chen, Dat Tran, et al.
Cardiovascular Drugs and Therapy|July 29, 2021
The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's PerspectiveKreton Mavromatis, Anthony Gershlick
Cardiovascular Drugs and Therapy|May 23, 2013
What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trialsFrançois Roubille, Fabrice Prunier, Stéphanie Barrère-Lemaire, et al.
Cardiovascular Drugs and Therapy|December 12, 2012
Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt ratsWensu Yuan, Yueyi Yu, Jingjing Li, et al.
Cardiovascular Drugs and Therapy|January 25, 2013
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat modelHiroyuki Takahama, Hirokazu Shigematsu, Tomohiro Asai, et al.
Cardiovascular Drugs and Therapy|February 6, 2013
Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiologyPeter Clemmensen, Nadia Paarup Dridi, Lene Holmvang
Cardiovascular Drugs and Therapy|March 8, 2013
Chymase inhibition and cardiovascular protectionHideaki Tojo, Hidenori Urata
Cardiovascular Drugs and Therapy|February 1, 1994
Diabetic cardiomyopathyF S Fein, E H Sonnenblick
Cardiovascular Drugs and Therapy|February 1, 1994
Alcoholic cardiomyopathyL Fabrizio, T J Regan
Cardiovascular Drugs and Therapy|February 1, 1994
Management of arrhythmias in hypertrophic cardiomyopathyJ T Stewart, W J McKenna
Pageof 302